Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)

Market Cap	2.54B +32.8%
Revenue (ttm)	1.01B -2.2%
Net Income	-110.67M
EPS	-0.97
Shares Out	112.55M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,216,235
Open	22.99
Previous Close	22.76
Day's Range	22.33 - 23.79
52-Week Range	17.03 - 24.70
Beta	0.73
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 1, 2026

About SHA:605177

Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 1,514
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 605177

Financial Performance

In 2025, SHA:605177's revenue was 940.19 million, a decrease of -21.54% compared to the previous year's 1.20 billion. Losses were -82.39 million, -18.15% less than in 2024.